HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of the antithrombotic and haemorrhagic effects of a low molecular weight heparin (LHN-1) and conventional heparin.

Abstract
The antithrombotic effects after intravenous administration of a low molecular weight heparin (LHN-1) and conventional heparin were compared in a rabbit model of experimental thrombosis, where thrombus formation was induced by a combination of endothelial damage and stasis. Both compounds were able to prevent thrombosis completely. However, LHN-1 was significantly less potent than conventional heparin, the ratio between doses with the same antithrombotic effect being 2.4:1 on a weight basis. Bleeding times after administration of LHN-1 and conventional heparin were determined by tail transsection in anaesthetized rats and by template bleeding in the ear of conscious pigs. Given intravenously at a dose ratio of 2.4:1 (w/w), LHN-1 affected APTT less than conventional heparin, whereas the effects on haemostasis were not significantly different. In conclusion, it was found that after intravenous administration LHN-1 prevented experimental thrombosis as effectively as conventional heparin. However, the correlation between antithrombotic and haemorrhagic effects of LHN-1 was the same as that of conventional heparin. The corresponding relation in man remains to be determined.
AuthorsV Diness, J I Nielsen, P C Pedersen, K H Wolffbrandt, P B Ostergaard
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 55 Issue 3 Pg. 410-4 (Jun 30 1986) ISSN: 0340-6245 [Print] Germany
PMID3750271 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Heparin
Topics
  • Animals
  • Bleeding Time
  • Female
  • Hemorrhage (chemically induced)
  • Hemostasis (drug effects)
  • Heparin (pharmacology)
  • Male
  • Partial Thromboplastin Time
  • Rabbits
  • Rats
  • Rats, Inbred Strains
  • Swine
  • Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: